Encouraging results for device to treat wAMD

Long-term positive outcomes of a minimally invasive retrobulbar episcleral brachytherapy device (SalutarisMD, Salutaris Medical Devices, London, UK) show promise for treating wet age-related macular degeneration (wAMD), according to data presented at the RCO congress.

Related Content:

ArticlesRetina

Application for Genentech’s faricimab accepted by U.S. FDA for treatment of wet AMD and DMO

Drug Delivery Methods Explored for Retinal Disease

Expanding the definition of AMD